MES Engineer (Night Shift)
Genentech · Hillsboro, OR · Manufacturing & Engineering
About this role
Genentech is hiring a senior-level Platform Engineer in the software engineering function based in Hillsboro, OR. The posting calls out experience with Testing. Compensation is listed at $78,900–$176,800 per year.
- Role
- Platform Engineer
- Function
- software engineering
- Level
- senior
- Track
- Individual contributor
- Employment
- Full-time
- Location
- Hillsboro, OR
- Department
- Manufacturing & Engineering
- Posted
- Jan 30, 2026
More roles at Genentech
Job description
from Genentech careersThe Position
Are you passionate about Information (IT) and Automation Technology (OT) and aspiring to make a meaningful impact? Are you curious to shape a digital manufacturing architecture, ready to advance competitiveness on the market? This role could be for you!
We Make Medicines!
Behind every product sold by Roche is Pharma Global Technical Operations (PT). Starting with Phase I of the development process and continuing through to product maturity, PT makes lifesaving medicines at 11 locations, with the support of partners from around the world. Information (IT) and Automation Technology (OT) teams are key in producing and delivering medicine to patients. The organization is currently undergoing a transformation towards digitalization, advancing fundamental elements to meet future needs, such as using new technologies.
The Opportunity
This position, based in Genentech's Hillsboro, Oregon facility, provides the opportunity to have a key role in a highly automated pharmaceutical drug substance facility. The site employs highly integrated computer control systems to manage plant operations and manufacturing data.
The IT OT Team in Hillsboro is supporting Hillsboro Technical Operations (HTO) which is the commercial Make Assess and Release (MAR) and launch site for North America, and Hillsboro Innovative Therapies (HIT) which is transitioning into a multi-product facility for development, clinical and commercial supply capabilities for individualized and cell therapies.